The Journal of Organic Chemistry
Article
organic layers were dried over Na2SO4 and concentrated under
reduced pressure. The crude product was purified by column
chromatography on silica (n-pentane/Et2O = 5:1) and (4S,5S)-5-
methyl-8-(tosyloxy)octan-4-yl acetate obtained as a yellowish liquid
(639 mg, 90%, 94:6 dr). To a solution of LiAlH4 (171 mg, 4.53 mmol,
3.00 equiv) in dry THF (4.53 mL) at 0 °C a solution of (4S,5S)-5-
methyl-8-(tosyloxy)octan-4-yl acetate (538 mg, 1.51 mmol) in dry
THF (2.16 mL) was added and heated to 75 °C for 5 h. After cooling
to 0 °C the reaction was quenched by the addition of MeOH (5 mL)
and a saturated aqueous solution of NaK-tatrate (10 mL) and
extracted with EtOAc (3 × 25 mL), and the combined organic layers
were dried over Na2SO4 and concentrated under reduced pressure.
The crude product was purified by column chromatography on silica
(n-pentane/Et2O = 10:1), and 10b was obtained as a colorless liquid
(210 mg, 96%, 97:3 dr). (4S,5S)-5-Methyl-8-(tosyloxy)octan-4-yl
acetate: [α]2D0 = −17.9° (c 1.30, CHCl3); 1H NMR (400 MHz,
CDCl3): δ 7.77 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.4 Hz, 2H), 4.79 (dt,
J = 8.8, 4.0 Hz, 1H), 3.94−4.03 (m, 2H), 2.44 (s, 3H), 2.01 (s, 3H),
1.07−1.74 (m, 9H), 0.88 (t, J = 7.3 Hz, 3H), 0.83 (d, J = 6.9 Hz, 3H);
13C NMR (100 MHz, CDCl3): δ 170.8, 144.6, 133.1, 129.7 (2C),
127.8 (2C), 76.3, 70.6, 35.8, 33.2, 28.6, 26.6, 21.5, 21.0, 18.9, 14.2,
13.8; IR 2960, 2874, 1731, 1598, 1462, 1360, 1244, 1188, 1177, 1120,
1097, 1020, 964, 917, 815, 664 cm−1; HRMS (ESI): m/z calcd for
C18H32O5NS [M + NH4]+ 374.19957, found 374.20048, calcd for
The crude product was purified by column chromatography on silica
(n-pentane/EtOAc = 250:1), and 11b (178 mg, 81%, 96:4 dr) was
obtained as a colorless liquid. [α]2D0 = −12.7 (c 1.13, CHCl3); 1H NMR
(400 MHz, CDCl3): δ 6.17 (d, J = 15.6 Hz, 1H), 5.61−5.68 (m, 1H),
4.87 (s, 2H), 3.53 (td, J = 6.1, 3.7 Hz, 1H), 2.23−2.30 (m, 1H), 2.02
(dt, J = 14.5, 7.5 Hz, 1H), 1.84 (s, 3H), 1.57−1.66 (m, 1H), 1.40−1.47
(m, 4H), 1.26−1.35 (m, 6H), 0.87−0.92 (m, 6H); 13C NMR (100
MHz, CDCl3): δ 141.9, 134.2, 129.2, 114.4, 74.6, 38.5, 36.9, 34.5, 31.9,
25.9, 22.6, 18.7, 14.0, 13.3; IR 3379, 2958, 2929, 2860, 1608, 1457,
1377, 1124, 1017, 965, 881 cm−1; HRMS (ESI) calcd for C14H27O [M
+ H]+ 211.20564, found 211.20571.
(4S,5S)-5-Butyl-4-methyldihydrofuran-2(3H)-one 12a,
(−)-cis-Whisky Lactone. A solution of 11a (80.0 mg, 0.40 mmol)
in MeOH (5 mL) was cooled to −78 °C, ozone enriched O2 was
bubbled through the solution until it turned blue, following by stirring
for 5 min, and air was bubbled through the solution until the blue
color disappeared. The reaction was quenched by the addition of
NaBH4 (36.3 mg, 0.96 mmol, 2.40 equiv), stirred for 1 h while
warming up to rt, and extracted with CH2Cl2 (3 × 5 mL), and the
combined organic layers were dried over MgSO4 and concentrated
under reduced pressure. The crude product was solved in MeCN (1
mL), and solutions of CuOTf·4MeCN (7.54 mg, 0.02 mmol, 0.05
equiv), 2,2′-bipyridine (3.13 mg, 0.02 mmol, 0.05 equiv), TEMPO
(3.13 mg, 0.02 mmol, 0.05 equiv), and 1-methylimidazole (3.29 mg,
0.04 mmol, 0.10 equiv) each in MeCN (1 mL) were added. The
reaction mixture was degassed for 5 min, the atmosphere in the
reaction vessel was replaced by O2, and the reaction was stirred for 2 h
at 50 °C, quenched by the addition of H2O (1 mL), and extracted with
CH2Cl2 (3 × 5 mL); the combined organic layers were dried over
MgSO4 and concentrated under reduced pressure. The crude product
was purified by column chromatography on silica (n-pentane/Et2O =
5:1), and 12a was obtained as a colorless liquid (50.0 mg, 73%, 98:2
dr). [α]2D0 = −59.2° (c 1.18, CHCl3); 1H NMR (400 MHz, CDCl3): δ
4.39−4.44 (m, 1H), 2.68 (dd, J = 17.0, 7.8 Hz, 1H), 2.53−2.61 (m,
1H), 2.18 (dd, J = 17.0, 4.0 Hz, 1H), 1.59−1.69 (m, 1H), 1.43−1.55
(m, 2H), 1.29−1.40 (m, 3H), 1.00 (d, J = 7.1 Hz, 3H), 0.91 (t, J = 7.1
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 176.8, 83.6, 37.5, 32.9, 29.5,
28.0, 22.4, 13.8, 13.8; IR 3523, 2958, 2873, 1774, 1465, 1422, 1383,
1336, 1293, 1209, 1170, 1092, 1080, 994, 974, 940, 928 cm−1; HRMS
(ESI) m/z calcd for C9H17O2 [M + H]+ 157.12231, found 157.12216.
(4S,5S)-4-Methyl-5-pentyldihydrofuran-2(3H)-one 12b,
(−)-cis-Cognac Lactone. The same procedure as above was applied
to 11b (127 mg, 0.60 mmol). The crude product was purified by
column chromatography on silica as above, and 12b (78.8 mg, 77%,
98:2 dr) was obtained as a colorless liquid. [α]2D0 = −64.8 (c 1.23,
C18H28O5NaS [M + Na]+ 379.15497, found 379.15546. 10b: [α]2D0
=
1
−31.9 (c 1.03, CHCl3); H NMR (400 MHz, CDCl3): δ 3.51 (dt, J =
7.5, 4.3 Hz, 1H), 1.24−1.54 (m, 9H), 1.12−1.20 (m, 1H), 0.93 (t, J =
7.2 Hz, 3H), 0.90 (t, J = 6.9 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H); 13C
NMR (100 MHz, CDCl3): δ 74.9, 37.9, 36.7, 35.6, 20.4, 19.4, 14.3,
14.1, 13.5; IR 3374, 2958, 2931, 2872, 1465, 1378, 1286, 1220, 1148,
1114, 1062, 1012, 970 cm−1; HRMS (ESI): m/z calcd for C9H19 [M +
H − H2O]+ 127.14813, found 127.14775.
(4S,5S)-4-Methylnonan-5-ol 10c, Ferrugineol. The same
procedure as above was applied to 9c (432 mg, 2.00 mmol). The
crude products were purified by column chromatography on silica as
above. (4S,5S)-4-Methyl-1-(tosyloxy)nonan-5-yl acetate (639 mg,
90%, 97:3 dr) and 10c (261 mg, 93%, 98:2 dr) were obtained as
yellowish or colorless liquids, respectively. (4S,5S)-4-Methyl-1-(tosyl-
oxy)nonan-5-yl acetate: [α]2D0 = −14.7 (c 1.39, CHCl3); 1H NMR (400
MHz, CDCl3): δ 7.77 (d, J = 8.4 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H),
4.78 (dt, J = 8.5, 4.4 Hz, 1H), 3.95−4.04 (m, 2H), 2.44 (s, 3H), 2.02
(s, 3H), 1.08−1.73 (m, 12H), 0.87 (t, J = 7.3 Hz, 3H), 0.84 (d, J = 6.9
Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 170.8, 144.6, 133.2, 129.7
(2C), 127.8 (2C), 76.5, 70.6, 35.8, 30.8, 28.6, 27.9, 26.6, 22.5, 21.5,
21.0, 14.2, 13.9; IR 2958, 2870, 1732, 1598, 1461, 1363, 1242, 1177,
1097, 1020, 955, 890, 815, 765 cm−1; HRMS (ESI) calcd for
1
CHCl3); H NMR (400 MHz, CDCl3): δ 4.41 (ddd, J = 9.4, 5.4, 4.4
C19H30O5NaS [M + Na]+ 393.17062, found 393.17096. 10c: [α]2D0
=
Hz, 1H), 2.67 (dd, J = 17.0, 7.8 Hz, 1H), 2.52−2.60 (m, 1H), 2.17
(dd, J = 17.0, 4.0 Hz, 1H), 1.63 (q, J = 9.3 Hz, 1H), 1.45−1.53 (m,
2H), 1.26−1.39 (m, 5H), 0.99 (d, J = 7.3 Hz, 3H), 0.85−0.91 (m,
3H); 13C NMR (100 MHz, CDCl3): δ 176.8, 83.6, 37.5, 32.9, 31.5,
29.8, 25.5, 22.4, 13.9, 13.7; IR 2956, 2865, 1779, 1462, 1423, 1383,
1335, 1294, 1212, 1168, 1079, 1006, 978, 932 cm−1; HRMS (ESI)
calcd for C10H19O2 [M + H]+ 171.13796, found 171.13783.
(2S,6S)-2,6-Dichloroheptane-1,7-diol 14. To a solution of
freshly distilled 1,7-heptandiol 13 (512 mg, 4.00 mmol) in MeCN
(40 mL) were added CuOTf·4MeCN (149 mg, 0.30 mmol, 0.075
equiv), 2,2′-bipyridine (46.8 mg, 0.30 mmol, 0.075 equiv), TEMPO
(46.8 mg, 0.30 mmol, 0.075 equiv), and 1-methylimidazole (49.7 mg,
0.60 mmol, 0.15 equiv). The reaction mixture was degassed for 5 min,
and the atmosphere in the reaction vessel was replaced by O2. The
reaction mixture was stirred for 3 h at rt, and (2R,5S)-2-(tert-butyl)-
3,5-dimethylimidazolidin-4-one-TFA-salt (457 mg, 1.60 mmol, 0.40
equiv) and NCS (1.33 g, 10.0 mmol, 2.50 equiv) were added
successively. The reaction was stirred for 18 h at rt, cooled to 0 °C,
and diluted with EtOH (40 mL). After successive addition of NaBH4
(756 mg, 20 mmol, 5.00 equiv) the reaction was stirred for 30 min at 0
°C, quenched by the addition of a saturated aqueous solution of
NH4Cl (20 mL), and extracted with EtOAc (3 × 60 mL). The
combined organic layers were dried over MgSO4 and concentrated
under reduced pressure. The crude product was purified by column
1
−27.2 (c 1.02, CHCl3); H NMR (400 MHz, CDCl3): δ 3.48 (dt, J =
7.9, 4.1 Hz, 1H), 1.23−1.52 (m, 11H), 1.11−1.19 (m, 1H), 0.91 (t, J =
7.1 Hz, 3H), 0.90 (t, J = 7.1 Hz, 3H), 0.86 (d, J = 6.9 Hz, 3H); 13C
NMR 75.1, 37.9, 35.6, 34.2, 28.5, 22.8, 20.4, 14.3, 14.0, 13.5; IR 3379,
2958, 2930, 2870, 1462, 1379, 1145, 1114, 1015, 974 cm−1; HRMS
+
(ESI) calcd for C10H21 [M + H − H2O]
141.16351.
141.16378, found
(5S,6S,E)-6,10-Dimethylundeca-8,10-dien-5-ol 11a. The same
procedure to synthesize 7a was applied to 6c (256 mg, 1.68 mmol),
using nPrMgCl (2.0 M in Et2O, 1.68 mL, 2.00 equiv). The crude
product was purified by column chromatography on silica (n-pentane/
EtOAc = 250:1−100:1), and 11a (244 mg, 74%, 94:6 dr) was obtained
as a colorless liquid. [α]D20 = −13.3 (c 1.23, CHCl3); H NMR (400
1
MHz, CDCl3): δ 6.17 (d, J = 15.6 Hz, 1H), 5.61−5.69 (m, 1H), 4.87
(s, 2H), 3.54 (td, J = 6.1, 3.7 Hz, 1H), 2.27 (dt, J = 13.7, 6.6 Hz, 1H),
1.98−2.06 (m, 1H), 1.84 (s, 3H), 1.57−1.66 (m, 1H), 1.24−1.48 (m,
7H), 0.87−0.94 (m, 6H); 13C NMR (100 MHz, CDCl3): δ 142.0,
134.2, 129.2, 114.4, 74.6, 38.5, 36.9, 34.2, 28.4, 22.7, 18.7, 14.0, 13.3;
IR 3380, 3080, 2958, 2930, 2871, 1646, 1608, 1457, 1378, 1312, 1123,
1004, 966, 881 cm−1; HRMS (ESI) calcd for C13H25O [M + H]+
197.18999, found 197.18996.
(6S,7S,E)-7,11-Dimethyldodeca-9,11-dien-6-ol 11b. The same
procedure to synthesize 7a was applied to 6c (158 mg, 1.04 mmol).
F
dx.doi.org/10.1021/jo402422b | J. Org. Chem. XXXX, XXX, XXX−XXX